RxDoctor Payments Data

Charles Hultman, MD

Plastic and Reconstructive Surgery · Raleigh, NCNPI 1245324243

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.2%), grants and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Avita Medical Americas, LLC at 56.3% of the total. Reporting peaked in 2023 at $35,778 and has fallen 95.6% since, to $1,582 in 2025. Among plastic and reconstructive surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,497in general payments, 2019–2025

Across 128 payments — averaging $550.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avita Medical Americas, LLC$40K
  • Vericel Corporation$25K
  • AbbVie$1K
  • Kerecis Limited$1K
  • Smith+Nephew$777
  • TELA Bio, Inc.$670
  • plus $3K from 15 others

What the payments were for

  • Consulting fees$37,52553%
  • Speaking & faculty fees$8,25012%
  • Grants$15,88923%
  • Travel & lodging$1,2622%
  • Food & beverage$7,57111%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,497 in reported general payments places this provider in the 90th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$110,105
Medicare patients
48
Services billed
508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →